Ratings by Northland (Suraj Kalia)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
8/9/2023 | BioLife Solutions | BLFS | Maintain | Outperform (N/A) |
|
Details | ||
12/28/2020 | BioLife Solutions | BLFS | Maintain | Outperform (N/A) |
|
Details | ||
12/18/2019 | BioLife Solutions | BLFS | Maintain | Outperform (N/A) |
|
Details | ||
9/3/2019 | BioLife Solutions | BLFS | Maintain | Outperform (N/A) |
|
Details | ||
8/19/2019 | ViewRay Inc. | VRAY | Maintain | Outperform (N/A) |
|
Details | ||
6/10/2019 | Insulet Corporation | PODD | Downgrade | Market Perform (Outperform) |
112.70 (169.18) |
50.12% | Details | |
3/19/2019 | Varex Imaging | VREX | New Coverage | Outperform (N/A) |
32.92 (17.63) |
-46.45% | Details | |
3/1/2019 | Tactile Systems Technology | TCMD | Maintain | Market Perform (N/A) |
|
Details | ||
1/29/2019 | Sensus Healthcare | SRTS | Downgrade | Underperform (Market Perform) |
8.18 (3.92) |
-52.08% | Details | |
1/2/2019 | Apollo Endosurgery | APEN | Upgrade | Market Perform (Underperform) |
3.45 (10.00) |
189.86% | Details | |
1/2/2019 | Tactile Systems Technology | TCMD | Upgrade | Market Perform (Underperform) |
45.55 (15.86) |
-65.18% | Details | |
12/10/2018 | Strata Skin Sciences | SSKN | New Coverage | Outperform (N/A) |
2.85 (0.44) |
-84.56% | Details | |
12/10/2018 | Strata Skin Sciences | SSKN | New Coverage | Outperform (N/A) |
2.78 (2.85) |
2.52% | Details | |
11/9/2018 | Apollo Endosurgery | APEN | Downgrade | Underperform (Market Perform) |
5.75 (3.45) |
-40% | Details | |
10/15/2018 | Sensus Healthcare | SRTS | Downgrade | Market Perform (Outperform) |
7.16 (8.18) |
14.25% | Details | |
9/17/2018 | Invuity | IVTY | New Coverage | Market Perform () |
7.35 (7.39) |
0.54% | Details | |
9/17/2018 | Titan Medical | TMDI | New Coverage | Outperform (N/A) |
1.92 (0.14) |
-92.71% | Details | |
9/13/2018 | iRhythm Technologies | IRTC | Maintain | Market Perform (N/A) |
|
Details | ||
9/12/2018 | DexCom | DXCM | Upgrade | Market Perform (Underperform) |
146.87 (139.48) |
-5.03% | Details |